Discontinued — last reported Q1 '18
Vertiv Holdings Co Allowance for Doubtful Accounts Receivable (Current) increased by 3.9% to $26.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.2%, from $23.10M to $26.60M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 2.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.90M | $13.00M | $14.10M | $15.20M | $15.40M | $15.90M | $18.40M | $24.30M | $24.50M | $26.60M | $29.10M | $31.60M | $26.90M | $26.30M | $22.40M | $23.10M | $24.30M | $25.30M | $25.60M | $26.60M |
| QoQ Change | — | -40.6% | +8.5% | +7.8% | +1.3% | +3.2% | +15.7% | +32.1% | +0.8% | +8.6% | +9.4% | +8.6% | -14.9% | -2.2% | -14.8% | +3.1% | +5.2% | +4.1% | +1.2% | +3.9% |
| YoY Change | — | — | — | — | -29.7% | +22.3% | +30.5% | +59.9% | +59.1% | +67.3% | +58.2% | +30.0% | +9.8% | -1.1% | -23.0% | -26.9% | -9.7% | -3.8% | +14.3% | +15.2% |